NIH-funded research R01 grant

Using MRI to study liver microstructure changes

Official title: in vivo MR characterization of pathological changes in liver microstructures

Funded at Vanderbilt University Medical Center · NIH-11017821 · Data updated 2026-11-12

This study is looking at new, safe MRI techniques to better understand liver problems, especially for people with nonalcoholic steatohepatitis (NASH), so that doctors can avoid the discomfort of liver biopsies while still getting accurate information to help manage your health.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionVanderbilt University Medical Center
NIH-funded
Lab location1 site (Nashville, United States)
Project startFebruary 1, 2024
Project endJanuary 31, 2028
Funding year2025
Award (this year)$355,538
NIH project number5R01DK135950-02
Project IDNIH-11017821 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with nonalcoholic steatohepatitis (NASH) or those at risk due to obesity or type 2 diabetes.

Less likely to help

Patients with liver diseases that are not related to NASH or those who have already undergone liver transplantation may not benefit from this research.

What this research studies

This research investigates non-invasive MRI techniques to characterize changes in liver microstructures associated with various liver diseases, particularly focusing on nonalcoholic steatohepatitis (NASH). By developing methods to assess liver inflammation, the study aims to provide a safer alternative to liver biopsies, which are currently the standard diagnostic tool but carry risks and discomfort for patients. The research will utilize advanced imaging to differentiate between types of liver conditions, potentially improving patient management and outcomes. This approach is particularly relevant given the rising prevalence of liver diseases linked to obesity and diabetes.

Why it matters

Potential benefit: If successful, this research could lead to safer, non-invasive diagnostic methods for liver diseases, reducing the need for biopsies and associated risks.

How similar studies have gone: Other research has shown promise in using non-invasive imaging techniques for liver disease assessment, but this specific approach to measuring inflammation in NASH is relatively novel.

Where this research is happening

  • Vanderbilt University Medical Center
    Nashville, United States
    Active

Researchers

  • Principal investigator: Jiang, Xiaoyu — Vanderbilt University Medical Center
  • Study coordinator: Jiang, Xiaoyu

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.